0001493152-24-017719.txt : 20240503 0001493152-24-017719.hdr.sgml : 20240503 20240503163042 ACCESSION NUMBER: 0001493152-24-017719 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240501 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CareCloud, Inc. CENTRAL INDEX KEY: 0001582982 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] ORGANIZATION NAME: 06 Technology IRS NUMBER: 223832302 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36529 FILM NUMBER: 24913668 BUSINESS ADDRESS: STREET 1: 7 CLYDE ROAD STREET 2: SOMERSET CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: 7328735133 MAIL ADDRESS: STREET 1: 7 CLYDE ROAD STREET 2: SOMERSET CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: MTBC, Inc. DATE OF NAME CHANGE: 20190206 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL TRANSCRIPTION BILLING, CORP DATE OF NAME CHANGE: 20130731 8-K 1 form8-k.htm
false 0001582982 0001582982 2024-05-01 2024-05-01 0001582982 CCLD:CommonStockParValue0.001PerShareMember 2024-05-01 2024-05-01 0001582982 CCLD:Sec11SeriesCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember 2024-05-01 2024-05-01 0001582982 CCLD:Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember 2024-05-01 2024-05-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 1, 2024

 

CARECLOUD, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-36529   22-3832302

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

7 Clyde Road, Somerset, New Jersey, 08873

(Address of principal executive offices, zip code)

 

(732) 873-5133

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   CCLD   Nasdaq Global Market
11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share   CCLDP   Nasdaq Global Market
8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share   CCLDO   Nasdaq Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective May 1, 2024, Stephen Snyder has been appointed President of CareCloud, Inc. (the “Registrant”). As of such date, A. Hadi Chaudhry is no longer President of the Registrant, but remains the Registrant’s Chief Executive Officer.

 

Mr. Snyder, 47, served as the Registrant’s Chief Executive Officer from January 2018 through March 2021, and served as the Registrant’s Chief Strategy Officer from March 2021 through June 2022. Effective June 2022, Mr. Snyder became a consultant to the Registrant.

 

On May 1, 2024, the Registrant entered into an executive employment agreement with Mr. Snyder.

 

Mr. Snyder’s annual base salary will be $300,000 (“Base Salary”). At the sole discretion of the Board of Directors, Mr. Snyder’s employment agreement entitles him to an annual bonus based upon the achievement of objectives established by the Board of Directors, with a target of up to 100% of the Base Salary. Upon termination due to a change of control of the Registrant, Mr. Snyder may receive severance of up to 24 months of his salary and bonus.

 

The initial term for his employment agreement began on May 1, 2024 and expires on April 30, 2026. The term of the employment agreement automatically renews for additional one-year terms unless either party elects to terminate the agreement by notice to the other party delivered at least ninety (90) days prior to the expiration of the initial or any renewal term. Notwithstanding the foregoing, the Registrant may terminate Mr. Snyder’s employment for any reason upon thirty (30) days’ advance written notice.

 

The employment agreement provides that Mr. Snyder (i) may serve on corporate, civic or charitable boards or committees; (ii) deliver lectures, fulfill speaking engagements or teach at educational institutions; and (iii) continue to operate and engage in such businesses as Mr. Snyder presently operates and engages, so long as such activities, separately or in the aggregate, do not materially interfere with the performance of his responsibilities as an employee of the Registrant.

 

There are no family relationships between Mr. Snyder and any director or executive officer of the Registrant. Mr. Snyder has no direct or indirect material interest in any related party transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K, except that during June 2022, the Registrant entered into a one-year consulting agreement (“Consulting Agreement”) with an entity owned and controlled by Mr. Snyder whereby Mr. Snyder received 10,000 shares of the Registrant’s 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”) in exchange for assisting the Registrant to identify and acquire additional companies. In addition, the Registrant may make additional payments under the Consulting Agreement for any successful acquisitions by the Registrant based on the purchase price of the transaction. No such additional payments have been made. During February 2023, the Consulting Agreement was amended and extended through December 2024 whereby Mr. Snyder received 14,000 shares of Series B Preferred Stock in February 2023 and received an additional 14,000 shares in January 2024. All such shares of the Series B Preferred Stock were issued in accordance with the Registrant’s Amended and Restated Equity Incentive Plan. The amendment also provides that any transaction fees due will be offset against the last two above payments before any amounts are due to Mr. Snyder. There were no transaction fees through April 30, 2024. In February 2024, the Registrant added an additional Statement of Work (“SOW”) to the Consulting Agreement, providing that Mr. Snyder’s entity would receive $25,000 per month for providing additional consulting services to the Registrant. The Consulting Agreement and SOW were terminated as of April 30, 2024. The Consulting Agreement, the amendment to the Consulting Agreement, and SOW were attached as Exhibits 10.22 and 10.23 to the Registrant’s Annual Report on Form 10-K, filed with the SEC on March 2, 2023 and Exhibit 10.27 to the Registrant’s Annual Report on Form 10-K, filed with the SEC on March 21, 2024, respectively.

 

The foregoing description of Mr. Snyder’s appointment as President and the key provisions of his employment agreement does not purport to be complete and is qualified entirely by reference to the terms of the actual executive employment agreement, a copy of which is attached as an exhibit to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
     
10.1   Stephen Snyder Executive Employment Agreement
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   CareCloud, Inc.
     
Date: May 3, 2024 By:

/s/ A. Hadi Chaudhry

    A. Hadi Chaudhry
    Chief Executive Officer

 

 

EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

CareCloud, Inc.

EXECUTIVE EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT, dated as of the 30th day of April, 2024 (“Employment Agreement”), is by and between CareCloud, Inc., a Delaware corporation (the “Company”) and Stephen Snyder (the “Executive”).

 

WHEREAS, the Executive possesses unique knowledge of the business and affairs of the Company, including its policies, methods, personnel and operations; and

 

WHEREAS, the Board of Directors of the Company (the “Board of Directors”) believes it to be in the best interests of the Company to ensure the Executive’s continued employment by the Company in the capacity and under the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of the foregoing and the mutual promises and agreements hereinafter set forth, the Company and Executive agree as follows:

 

1. Effective Date. This Employment Agreement shall become effective on May 1, 2024 (the “Effective Date”).

 

2. Employment. The Company hereby employs the Executive as its President, and the Executive hereby accepts employment all upon the terms and conditions herein set forth.

 

3. Duties. The Executive shall perform such management duties for the Company and its affiliates as may from time to time be assigned and which are consistent with his title of President. The Executive hereby promises to perform and discharge, well and faithfully, all duties of his position. If Executive is elected as a director or officer of any affiliate of the Company, the Executive shall serve in such capacity or capacities without further compensation.

 

4. Extent of Services.

 

(a) The Executive shall devote his time, attention and energies to the business of the Company and shall not, except as otherwise set forth herein, during the term of this Employment Agreement be engaged in any other business activity whether or not such business activity is pursued for gain, profit or other pecuniary advantage; but this shall not be construed as preventing the Executive from investing his personal assets in businesses which do not compete with the Company in such form or manner as will not require any services on the part of the Executive in the operation of the affairs of the companies in which such investments are made and in which his participation is solely that of an investor, nor shall this be construed as preventing the Executive from purchasing securities in any company whose securities are regularly traded provided that such purchases shall not result in his collectively owning beneficially at any time one percent (1%) or more of the equity securities of any company engaged in a business competitive to that of the Company, without the express prior written consent of the Company.

 

(b) It shall not be a violation of this Agreement for the Executive to serve on corporate, civic or charitable boards or committees; or deliver lectures, fulfill speaking engagements or teach at educational institutions; or continue to operate and engage in such businesses as Executive presently operates and engages, so long as such activities, separately or in the aggregate, do not materially interfere with the performance of the Executive’s responsibilities as an employee of the Company in accordance with this Agreement.

 

5. Compensation.

 

(a) For services rendered under this Employment Agreement, the Company shall pay the Executive a salary determined annually by the Board of Directors (the “Base Salary”), payable (after deduction of applicable payroll taxes) in the same manner and on the same payroll schedule in which Company employees receive payment. The Executive’s Base Salary commencing on the Effective Date shall be $300,000 per year. The Executive shall also be eligible for and participate in such fringe benefits as shall be generally provided to executives of the Company, including those under the CareCloud, Inc. Amended and Restated Equity Incentive Plan which may be adopted from time to time during the term.

 

 

 

 

(b) The Board of Directors shall review the Executive’s compensation at least once a year and effect such increases in the Base Salary as the Board of Directors, in its sole discretion, determines are merited, based upon the Executive’s performance and consistent with the Company’s compensation policies. At the conclusion of each Fiscal Year, the Executive shall be eligible for, and the Board of Directors in its sole discretion may award, an executive bonus based on the achievement of objectives established by the Board of Directors in line with the rules of the Company’s bonus plan. Executive’s Target Bonus is equal to 100% of the Base Salary.

 

6. Paid Time Off. During the term of this Employment Agreement, the Executive shall be entitled to the same number of paid days off pursuant to the Company’s customary paid time off policy as he has on the date of this Employment Agreement.

 

7. Expenses. During the term of this Employment Agreement, the Company shall reimburse the Executive for all reasonable out-of-pocket expenses incurred by the Executive in connection with the business of the Company and in performance of his duties under this Employment Agreement upon the Executive’s presentation to the Company of an itemized accounting of such expenses with reasonable supporting data.

 

8. Term. The Executive’s employment under this Employment Agreement shall commence on the Effective Date and shall expire on the two-year anniversary of the Effective Date. The term of employment shall automatically be extended for consecutive periods of one (1) year each unless notice of termination of employment is given by either party hereto at least ninety (90) days prior to the expiration of the initial or any renewal term, in which case, this Agreement shall terminate at the end of such initial or renewal term, as the case may be. In the case of a renewal and unless otherwise agreed to in writing by the parties, the terms and conditions of this Employment Agreement shall apply to any renewals or extensions thereto. Notwithstanding the foregoing, the Company may:

 

(i) Terminate the Executive’s employment hereunder for any reason or no reason, in the Company’s sole discretion, upon thirty (30) days’ advance written notice; or

 

(ii) Effect, which shall terminate the Executive’s employment hereunder, a Change of Control, which for purposes of this Agreement, unless the Board of Directors determines otherwise, shall be deemed to have occurred at such time as: (A) any person (as the term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act)) is or becomes the beneficial owner (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of voting securities of the Company representing more than 50% of the Company s outstanding voting securities or rights to acquire such securities except for any voting securities issued or purchased under any employee benefit plan of the Company or its subsidiaries, (B) any sale, lease, exchange or other transfer (in one transaction or a series of transactions) of all or substantially all of the assets of the Company, (C) a plan of liquidation of the Company or an agreement for the sale or liquidation of the Company is approved and completed, or (D) the Board of Directors determines in its sole discretion that a Change in Control has occurred, whether or not any event described above has occurred or is contemplated; or

 

(iii) Terminate the Executive’s employment upon the death of the Executive.

 

9. Payment Upon Termination.

 

(a) If this Employment Agreement is terminated pursuant to paragraph 8(i) above, the Executive shall not receive any severance pay unless otherwise provided by the Company’s severance pay policies that are generally applicable to all employees, if any.

 

 

 

  

(b) If this Employment Agreement is terminated pursuant to paragraph 8(ii) above, the Executive shall receive salary continuation pay for the remainder of the contractual term, but not in any event for less than twenty-four months from the date of such termination (“Salary Continuation Period”), equal to the Executive’s most recent annual salary plus his target bonus (as determined under the bonus plan last in effect for the Executive). In addition, the Company shall pay the premiums necessary to continue Executive’s group health coverage for the Salary Continuation Period under the applicable provisions of the Consolidated Omnibus Budget Reconciliation Act (“COBRA”), provided Executive elects to continue and remains eligible for those benefits under COBRA, and does not become eligible for health coverage through another employer during this period; provided, however, that the salary continuation payments, bonus and other benefits described in this paragraph 9(b) shall cease if the Executive shall, directly or indirectly, be in breach of his obligations under paragraph 13 hereof. Such salary continuation payments (less applicable payroll taxes) shall be paid periodically to the Executive as provided in paragraph 5(a) for the payment of the Base Salary.

 

(d) If the Company shall decide not to renew this Employment Agreement, the Executive’s employment shall be deemed terminated pursuant to paragraph 8(i) above.

 

(e) During the Salary Continuation Period, the Executive shall be under no obligation to mitigate the costs to the Company of the salary continuation or severance payments, and, no compensation that the Executive may receive from another employer during the Salary Continuation Period shall be offset against amounts owed to Executive hereunder. Notwithstanding the foregoing, in order to be entitled to the payments, if any, under paragraphs 9(a) and (b), Executive shall be required to execute and deliver (and not revoke) a release of all employment related claims against the Company in a form attached hereto as Exhibit A.

 

10. Representations. The Executive hereby represents to the Company that (a) he is legally entitled to enter into this Employment Agreement and to perform the services contemplated herein and is not bound under any employment or consulting agreement to render services to any third party, (b) he has the full right, power and authority, subject to no rights of third parties, to grant to the Company the rights contemplated by paragraph 11 hereof, and (c) he does not now have, nor within the last three years has had, any ownership interest in any business enterprise (other than interest in publicly traded companies where his ownership does not exceed one percent (1%) or more of the equity capital) other than Hill City Advisors, LLC, which is a customer of the Company, any of its subsidiaries, or from which the Company or any of its subsidiaries purchases any goods or services or to whom such Companies owe any financial obligations or are required or directed to make any payments.

 

11. Inventions. The Executive hereby sells, transfers and assigns to the Company or to any person or entity designated by the Company all of the entire right, title and interest of the Executive in and to all inventions, ideas, disclosures and improvements, whether patented or unpatented, and copyrightable material, made or conceived by the Executive, solely or jointly, during the term hereof which relate to methods, apparatus, designs, products, processes or devices, sold, leased, used or under consideration or development by the Company or any of its affiliates or which otherwise relate to or pertain to the business, functions or operations of the Company or any of its affiliates or which arise from the efforts of the Executive during the course of his employment for the Company or any of its affiliates. The Executive shall communicate promptly and disclose to the Company, in such form as the Company requests, all information, details and data pertaining to the aforementioned inventions, ideas, disclosures and improvements; and the Executive shall execute and deliver to the Company such formal transfers and assignments and such other papers and documents as may be necessary or required of the Executive to permit the Company or any person or entity designated by the Company to file and prosecute the patent applications and, as to copyrightable material, to obtain copyright thereof. Any invention relating to the business of the Company and its affiliates and disclosed by the Executive within one year following the termination of this Employment Agreement shall be deemed to fall within the provisions of this paragraph unless proved to have been first conceived and made following such termination.

 

12. Disclosure of Information. The Executive recognizes and acknowledges that the trade secrets, know-how and proprietary processes of the Company and its affiliates as they may exist from time to time are valuable, special and unique assets of the business of the Company and its affiliates, access to and knowledge of which are essential to the performance of the Executive’s duties hereunder. The Executive will not, during or after the term of his employment by the Company or any of its affiliates, in whole or in part, disclose such secrets, know-how or processes to any person, firm, Company, association or other entity for any reason or purpose whatsoever, nor shall the Executive make use of any such property for his own purposes or for the benefit of any person, firm, Company or other entity (except the Company and its affiliates) under any circumstances during or after the term of his employment, provided that after the term of his employment these restrictions shall not apply to such secrets, know-how and processes which are then in the public domain (provided that the Executive was not responsible, directly or indirectly, for such secrets, know-how or processes entering the public domain without the Company’s consent).

 

 

 

 

13. Non-Competition. During the term of Executive’s employment hereunder, unless otherwise provided for herein, and for a period beginning on the date of termination of Executive’s employment hereunder for any reason and ending on the later of one (1) year after the date of this Agreement or one (1) year after any such termination of employment (“Non-Competition Period”) Executive shall not, without the prior written consent of the Company, directly or indirectly:

 

(a) as an executive, employer, agent, principal, proprietor, partner, stockholder, consultant, employee, director, or corporate officer, engage in any business or render any services to any business that is in competition with the business of the Company; and

 

(b) solicit any employee of the Company to engage in a competitive business; or

 

(c) solicit customers of the Company on behalf of any company or entity whose business is competitive with the Company.

 

If the scope of any restrictions contained in Subsections (a), (b) or (c) of this Section 13 are too broad to permit enforcement of such restrictions to their full extent, then such restrictions shall be enforced to the maximum extent permitted by law, and Executive hereby consents and agrees that such scope may be judicially modified accordingly in any proceeding brought to enforce such restrictions.

 

14. Injunctive Relief. If there is a breach or threatened breach of the provisions of paragraph 11, 12 or 13 of this Employment Agreement, the Company shall be entitled to an injunction restraining the Executive from such breach. Nothing herein shall be construed as prohibiting the Company from pursuing any other remedies for such breach or threatened breach.

 

15. Insurance. The Company may, at its election and for its benefit, insure the Executive against accidental loss or death, and the Executive shall submit to such physical examination and supply such information as may be required in connection therewith.

 

16. Notices. Any notice required or permitted to be given under this Employment Agreement shall be sufficient if in writing and if sent by registered mail to the Executive at his home address as reflected on the records of the Company, in the case of the Executive, or CareCloud, Inc., 7 Clyde Road, Somerset New Jersey 08873, in the case of the Company.

 

17. Waiver of Breach. A waiver by the Company or the Executive of a breach of any provision of this Employment Agreement by the other party shall not operate or be construed as a waiver of any subsequent breach by the other party.

 

18. Governing Law. This Employment Agreement shall be governed by and construed and enforce in accordance with the laws of the State of New Jersey without giving effect to the choice of law or conflict of laws provisions thereof.

 

19. Assignment. This Employment Agreement may be assigned, without the consent of the Executive, by the Company to any of its affiliates, or to any other person, partnership, company, or other entity which has purchased substantially all the assets of the Company, provided such assignee assumes all the liabilities of the Company hereunder.

 

20. Severability. If any provision of any part of this Agreement is determined to be invalid or unenforceable, such invalidity or unenforceability shall not invalidate or render unenforceable any other portion of this Agreement. The entire Agreement shall be construed as if it did not contain the particular invalid or unenforceable provision(s) and the rights and obligations of the Parties shall be construed and enforced accordingly.

 

21. Entire Agreement; Amendment. This Employment Agreement contains the entire agreement of the parties and supersedes any and all agreements, letter of intent or understandings between the Executive and (a) the Company, (b) any of the Company’s principle shareholders, affiliates or subsidiaries regarding employment. This Employment Agreement may be amended or changed only by an agreement in writing signed by a party against whom enforcement of any waiver, change, modification, extension or discharge is sought.

 

[Signature page follows]

 

 

 

 

IN WITNESS WHEREOF, the parties have executed this Employment Agreement as of the day first herein above written.

 

EXECUTIVE

 

By: /s/ A. Stephen Snyder  
  Stephen Snyder  

 

CareCloud, Inc.

 

By: /s/ A. Hadi Chaudhry  
  A. Hadi Chaudhry  
  Chief Executive Officer  

 

 

 

 

EXHIBIT A

 

SEPARATION AGREEMENT AND RELEASE

 

I, Stephen Snyder, hereby acknowledge that CareCloud, Inc. (“the Company”) has advised me by letter dated _____________________(“the Letter”) of the pay and benefits to which I am entitled in connection with the separation of my employment with the Company, and the separation pay which it has agreed to pay to me in exchange for my signing this Separation Agreement and Release (“Release”). I further hereby acknowledge that the Company has advised me that I have a period of forty-five (45) days from the date of such Letter to sign the Release. I also understand that I have a period of seven (7) days following the date of my signature on the Release to change my mind and cancel this Release by sending a written revocation notice to the attention of the CEO, 7 Clyde Road, Somerset, NJ 08873. I understand that this Release is not enforceable until after the end of the seven (7) day period. I understand and agree that, should I revoke my Release, I will return any severance pay paid to me by the Company in exchange for signing the Release.

 

In consideration of such separation pay as set forth above and in the Letter, to which I acknowledge I am not otherwise entitled, I hereby voluntarily release the Company, the Company’s respective associates, affiliates, predecessors, successors, subsidiaries, parents, or agents of any of them, and the directors, officers, employees and agents of any of them, and shareholders (all the parties mentioned immediately before shall be referred to as the “Released Parties”) from, and waive any right to personal benefit arising from any proceedings or lawsuits, in connection with any and all claims relating to my employment, or the separation of my employment which I have or may have or acquire up to the date of my signature on this Release, including, but not limited to, claims of discrimination whether arising under Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act of 1967 as amended, the Older Workers Benefit Protection Act, the Rehabilitation Act of 1973, the Americans with Disabilities Act, the Civil Rights Act of 1991 or any other federal, state or local law. Moreover, I release all claims and waive all rights to file a judicial action and to receive personal benefit in connection with any other proceeding against the Released Parties arising from claims of breach of contract, claims for benefits other than those required by applicable law, claims for additional compensation and/or commissions, claims that the separation of my employment was wrongful, unjust or a violation of public policy or any other claim arising out of any matter concerning the Company or Released Parties in any form which may have occurred prior to the date of my signature on this Release.

 

I agree that I will not, directly or indirectly, engage in any conduct or make any statement disparaging or criticizing in any way the Company or any of its subsidiaries or affiliates or any of their respective officers, directors or employees nor shall you, directly or indirectly, engage in any conduct or make any statement that could be reasonably expected to impair the goodwill or reputation of the Company or any of its subsidiaries or affiliates, in each case, except to the extent required by law, and then only after consultation with the Company to the extent possible. The Company agrees it will use its reasonable efforts to ensure that the Company does not, directly or indirectly, engage in any conduct or make any statement disparaging or criticizing you in any way, or engage in any other conduct or make any other statement that could be reasonably expected to impair your business reputation, except to the extent required by law, and then only after consultation with Executive to the extent possible; provided, that any refusal by the Company to give a reference shall not be a breach of this provision.

 

I recognize that this Release shall be binding upon and apply to all of my heirs, executors, administrators, successors and assigns. In the event that state law restricts general releases and provides me with statutory rights, I also waive my right to such statutory protection to the full extent lawfully possible. This Release shall run to and benefit the Company and its respective associates, affiliates, predecessors, successors, subsidiaries, parents, or agents of any of them, assigns and the past and present directors, officers, agents, and employees.

 

[Signature page follows]

 

 

 

 

I agree that the Company has advised me in writing of my right to consult with an attorney prior to signing this Release and has provided me with sufficient time to review and sign the Release. I have carefully read and fully understand the contents of the Release and my voluntary signature is evidence of my intent to be legally bound by its terms.

 

     
(Print or Type Name)   (Witness Name - Printed or Typed)
     
     
Signature   Witness Signature

 

Date     Date  

 

 

EX-101.SCH 3 ccld-20240501.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 ccld-20240501_def.xml XBRL DEFINITION FILE EX-101.LAB 5 ccld-20240501_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.001 per share 11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 ccld-20240501_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
May 01, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date May 01, 2024
Entity File Number 001-36529
Entity Registrant Name CARECLOUD, INC.
Entity Central Index Key 0001582982
Entity Tax Identification Number 22-3832302
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 7 Clyde Road
Entity Address, City or Town Somerset
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08873
City Area Code (732)
Local Phone Number 873-5133
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock, par value $0.001 per share  
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol CCLD
Security Exchange Name NASDAQ
11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share  
Title of 12(b) Security 11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share
Trading Symbol CCLDP
Security Exchange Name NASDAQ
8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share  
Title of 12(b) Security 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share
Trading Symbol CCLDO
Security Exchange Name NASDAQ
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 4 22 1 false 3 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://carecloud.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ccld-20240501.xsd ccld-20240501_def.xml ccld-20240501_lab.xml ccld-20240501_pre.xml form8-k.htm http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "CCLD", "nsuri": "http://carecloud.com/20240501", "dts": { "schema": { "local": [ "ccld-20240501.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "ccld-20240501_def.xml" ] }, "labelLink": { "local": [ "ccld-20240501_lab.xml" ] }, "presentationLink": { "local": [ "ccld-20240501_pre.xml" ] }, "inline": { "local": [ "form8-k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 3, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 4, "entityCount": 1, "segmentCount": 3, "elementCount": 66, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 28 }, "report": { "R1": { "role": "http://carecloud.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-05-01", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-05-01", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://carecloud.com/role/Cover" ], "auth_ref": [] }, "CCLD_CommonStockParValue0.001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://carecloud.com/20240501", "localname": "CommonStockParValue0.001PerShareMember", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.001 per share" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "CCLD_Sec11SeriesCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://carecloud.com/20240501", "localname": "Sec11SeriesCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share" } } }, "auth_ref": [] }, "CCLD_Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://carecloud.com/20240501", "localname": "Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://carecloud.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001493152-24-017719-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-017719-xbrl.zip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end XML 18 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001582982 2024-05-01 2024-05-01 0001582982 CCLD:CommonStockParValue0.001PerShareMember 2024-05-01 2024-05-01 0001582982 CCLD:Sec11SeriesCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember 2024-05-01 2024-05-01 0001582982 CCLD:Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember 2024-05-01 2024-05-01 iso4217:USD shares iso4217:USD shares false 0001582982 8-K 2024-05-01 CARECLOUD, INC. DE 001-36529 22-3832302 7 Clyde Road Somerset NJ 08873 (732) 873-5133 false false false false Common Stock, par value $0.001 per share CCLD NASDAQ 11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share CCLDP NASDAQ 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share CCLDO NASDAQ false